|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.400 EUR | +30.84% |
|
+29.87% | -19.08% |
| 06-23 | Advicenne secures its cash runway through the second quarter of 2027 |  |
| 06-23 | Advicenne secures its cash runway through the second quarter of 2027 | |
| Market Cap | 15.57M 17.75M 14.35M 13.43M 25.19M 1.67B 25.71M 172M 66.73M 828M 66.66M 65.21M 2.87B | P/E 2026 * |
-2.28x | P/E 2027 * | -2.43x |
|---|---|---|---|---|---|
| Enterprise Value | 38.67M 44.1M 35.64M 33.37M 62.57M 4.16B 63.87M 428M 166M 2.06B 166M 162M 7.13B | EV / Sales 2026 * |
5.86x | EV / Sales 2027 * | 5.6x |
| Free-Float |
95.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +30.84% | ||
| 1 week | +29.87% | ||
| Current month | +60.00% | ||
| 1 month | +60.00% | ||
| 3 months | -2.10% | ||
| 6 months | -20.45% | ||
| Current year | -19.08% |
| 1 week | 1 |  | 1.4 |
| 1 month | 1 | | 1.45 |
| Current year | 0.8 | | 2.35 |
| 1 year | 0.8 | | 2.35 |
| 3 years | 0.8 | | 3.95 |
| 5 years | 0.8 | | 10.5 |
| 10 years | 0.8 | | 16.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 2021-05-02 |
Delphine Dumas
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-31 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
André Ulmann
BRD | Director/Board Member | - | 2017-06-22 |
Catherine Dunand
BRD | Director/Board Member | 64 | 2017-03-08 |
Charlotte Sibley
BRD | Director/Board Member | 78 | 2018-09-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-12-29 | Sell | General Counsel | 998 | 0.0123% | ||
| 20-12-28 | Sell | General Counsel | 1,000 | 0.0124% | ||
| 20-12-24 | Sell | General Counsel | 1,000 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +30.84% | +29.87% | +0.86% | -63.06% | 17.75M | |
| +2.06% | +3.76% | +21.48% | -9.59% | 64.39B | |
| +1.04% | +5.49% | +56.45% | +226.66% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| +0.45% | +2.22% | -51.82% | -58.54% | 37.98B | |
| +6.97% | +9.89% | +71.34% | -23.94% | 31.89B | |
| +12.59% | +5.18% | +147.68% | -45.31% | 26.69B | |
| +5.78% | +15.81% | +66.37% | +86.63% | 22.73B | |
| +6.52% | +6.24% | +2.10% | +176.51% | 16.66B | |
| -1.89% | +2.52% | +58.22% | +119.86% | 16.6B | |
| Average | +6.11% | +4.36% | +40.70% | +44.35% | 31.36B | |
| Weighted average by Cap. | +2.70% | +4.57% | +40.50% | +51.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.6M 7.53M 6.08M 5.7M 10.68M 710M 10.9M 73.12M 28.29M 351M 28.27M 27.65M 1.22B | 8M 9.12M 7.37M 6.9M 12.95M 861M 13.21M 88.63M 34.3M 425M 34.26M 33.51M 1.48B |
| Net income | -6.7M -7.64M -6.18M -5.78M -10.84M -721M -11.07M -74.23M -28.72M -356M -28.69M -28.07M -1.24B | -6.2M -7.07M -5.71M -5.35M -10.03M -667M -10.24M -68.69M -26.58M -330M -26.55M -25.97M -1.14B |
| Net Debt | 23.1M 26.35M 21.29M 19.93M 37.38M 2.49B 38.16M 256M 99.03M 1.23B 98.93M 96.77M 4.26B | 29.2M 33.3M 26.92M 25.2M 47.25M 3.14B 48.23M 324M 125M 1.55B 125M 122M 5.38B |
Employees
11
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | €1.400 | +30.84% | 138,391 |
| 26-06-26 | €1.070 | +4.49% | 30,144 |
| 26-06-25 | €1.024 | +1.59% | 10,343 |
| 26-06-24 | €1.008 | -1.18% | 20,228 |
| 26-06-23 | €1.020 | -5.38% | 41,310 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.070EUR
Average target price
4.000EUR
Spread / Average Target
+273.83%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALDVI Stock
Select your edition
All financial news and data tailored to specific country editions
